שווי כולל של החברה: knowlabs.co (USBC)

USBC Inc (USBC) is expanding its capabilities by developing non-invasive glucose monitoring systems utilizing radio-frequency sensors. The company is focused on R&D efforts, aiming to eliminate painful finger-pricks for diabetics. This price chart shows an Enterprise Value of 174.30, while strict FDA oversight and unique biosensor patents provide the enterprise with a significant moat against new market entrants.

USBC Inc (USBC) focuses on creating unique medical patents, aiming to secure a technological niche away from direct competition. By analyzing the company's total market valuation, an investor sees the sum of market capitalization and debt minus cash, which reflects the actual cost of acquiring the business and allows for an objective assessment of the asset's value considering its debt load.